Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$29.0 - $47.27 $217,790 - $354,997
-7,510 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$48.48 - $78.23 $148,348 - $239,383
3,060 Added 68.76%
7,510 $379,000
Q1 2021

Apr 27, 2021

BUY
$53.8 - $81.53 $239,410 - $362,808
4,450 New
4,450 $254,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.95B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Illinois Municipal Retirement Fund Portfolio

Follow Illinois Municipal Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Illinois Municipal Retirement Fund with notifications on news.